Kimberley Brown

Kimberley Brown Email and Phone Number

Vice President, Global Medical Leader, Cabotegravir @ ViiV Healthcare
Kimberley Brown's Location
New York City Metropolitan Area, United States, United States
About Kimberley Brown

Led Phase I-IV research for HIV and HCVExperience in leading NDA submissions for Ph I-III studiesMedical Lead for Ad/Promo MaterialsIntegrated Evidence Generation LeadClose partnership with R&D to align on strategy and publicationGenerated responses to Health AuthoritiesTraining for commercial and medical field teamsKOL Engagement

Kimberley Brown's Current Company Details
ViiV Healthcare

Viiv Healthcare

View
Vice President, Global Medical Leader, Cabotegravir
Kimberley Brown Work Experience Details
  • Viiv Healthcare
    Vice President, Global Medical Leader, Cabotegravir
    Viiv Healthcare Feb 2023 - Present
    Brentford, England, Gb
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Head, Infectious Diseases
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Jan 2022 - Jan 2023
    Raritan, New Jersey, Us
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Head (Sr Director), Field Medical
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Nov 2019 - Jan 2022
    Raritan, New Jersey, Us
    A key leadership position serving on the US Medical Affairs Sr. Leadership team, reporting to the VP of US MAF Strategic and tactical lead for Infectious Disease therapeutics (HIV, Hepatitis, RSV) and prevention efforts (COVID, RSV, HIV, and ExPEC)Oversees the Field Medical Affairs strategy for Medical Science Liaisons (MSLs) and Community Liaisons with dissemination of medical information among health care professionals, other key external stakeholders, and the communityOversees the process of obtaining insights and translating to actionable items (i.e. ensuring the creation of high-quality content slide decks, medical presentations at conferences, advisory boards, and insight gatherings, support of R&D and Medical Affairs studies) Led collaboration between US MAF MSLs and JNJ Global Public Health Medical Staff to foster Global Market Expertise Medical Insight Generation for ID pipeline and marketed products as well as vaccines
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Scientific Director, Research And Development
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Mar 2018 - Nov 2019
    Raritan, New Jersey, Us
    ▪ Contribute to trial design through creation of the PED, protocol, SAP, protocol specific PV criteria, participate in the DSMB/DMC; Answer trial related medical questions and interact with investigators/sites, CROs, etc; Perform medical review and safety analysis of clinical trial subjects; including periodic completion of the Safety Management Plan for individual trials; Assist in the determination whether new safety information requires an Amendment to the CTP and/or ICF; Assess Protocol Violations ▪ Review and approval of “AE coding” and “concomitant medication” lists, Review PV listings, Assist in creation and preparation of the safety part of Top Line Results presentation, CSRs and narratives, abstracts, presentations, and publications; Assist in ADR review and adjudication, Assist in labeling process; Contribute to presentation of trial results▪ Report regularly and work closely with Global Medical Leader, Interact with clinicians/experts (e.g. Advisory boards) as necessary, Act as a support to and resource for Medical Affairs, Assist in the creation of regulatory/submission documents (e.g. clinical summaries, clinical overviews, ASR, IND update)▪ Participation and cooperation in Clinical Team and in other Cross-functional teams, ad hoc, perform medical monitoring on Phase III and Phase IV studies in conjunction with IMPAACT
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Us Medical Director-Hiv Portfolio
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Jan 2015 - Mar 2018
    Raritan, New Jersey, Us
    ▪Responsible for various clinical leadership tasks such as providing US clinical perspective on global and publication teams, develop product and disease state strategy, participate in US label discussions and post approval commitments (i.e., Led a Phase IIIb study which led to sNDA approval for the USPI)▪Provide medical input for launch teams, ongoing training for our portfolio and competitor products. (including training, strategy, and development of tools to be used in the field)▪Obtain feedback on company strategy by establishing and maintaining international/national KOL relationships via meetings, advisory boards, and leading speaker training▪Serves as the medical lead for promotional review activities (PRC) to ensure medically accurate and balanced assets to support the brand▪Responsible for data generation activities including the design, protocol development, implementation, and execution of Phase IIIb/IV clinical trials for HIV and HCV (served as SRS a Ph IV HCV study, Ph IIIb PK study in pregnant women, and a Ph I relative bioavailbilty study in healthy volunteers)Served as the Integrated evidence generation lead to create real world evidence (RWE) for payers, integrated delivery networks, KOLs and HCPs by working with external data sources▪Review various CSRs and SAPs, develop and maintain clinical trial strategy that is aligned with marketing strategy, provides strategic feedback to ensure alignment with all regions and to anticipate a change in market dynamics), participates in post IIS approval study interactions with investigators
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Associate Medical Director, Infectious Diseases
    The Janssen Pharmaceutical Companies Of Johnson & Johnson May 2013 - Jan 2015
    Raritan, New Jersey, Us
    ▪ Responsible for various clinical leadership tasks such as providing US clinical perspective on global and publication teams (CDT, GCT, etc), develop product and disease state strategy, participate in US label discussions and post approval commitments, provide medical input for launch teams (including training, strategy, and development of tools to be used in the field), lead or provide input on presentations at medical and commercial advisory boards (including President’s Council), attend major medical conferences, establish and maintain KOL relationships, train commercial and various MAF teams (including extending MAF teams) on new clinical data, interface with MSL and extended MAF teams (HECOR, Sci Comm/Pubs) on medical strategy, participates in APR discussions, serves as the medical lead for promotional review activities (PRC) for the HIV and HCV disease state and product portfolios (PREZISTA INTELENCE, EDURANT, COMPLERA, and OLYSIO) Responsible for data generation activities including the execution of Phase IIIb/IV clinical trials for HIV and HCV (serve as SRS on SONET and TMC114HIV3015), review various CSRs and SAPs, develop and maintain clinical trial strategy that is aligned with marketing strategy, serve on research calls, participates in post IIS approval study interactions with investigators▪ Serves as clinical lead in various data dissemination activities such as providing a clinical perspective at major medical conferences/pre-cons, delivers presentations at regional clinical meetings, serves as medical lead for PRC, partners with marketing on strategy, slide development, meeting presentations, and training for the promotional speakers bureau, HIV and HCV PAT, med info publication reviews▪ Serves as the PVofficer and ensures that all safety and reporting responsibilities are met, participates in monthly safety and REMS team calls, serves as a liaison between GMS, NA Pharm LSO, and Janssen Therapeutics
  • Janssen-Pharmaceutical Companies Of Johnson & Johnson (Formerly Tibotec)
    Associate Director, Science And Research Liaisons
    Janssen-Pharmaceutical Companies Of Johnson & Johnson (Formerly Tibotec) Nov 2010 - May 2013
    Be
     Responsible for ensuring therapeutic area knowledge and leading business process and IT-related initiatives for the SRL team.  Coordinates training and skills assessment initiatives for SRLs, as well as for other Clinical Affairs partners, that concentrate on therapeutic knowledge, integration and application of clinical affairs strategies, and excellence in customer focus. Proactively identifies training needs and maintains training records. Also responsible for therapeutic training and on- boarding of new SRLs and partnerships with sales training Leads and coordinates overall efforts in design and implementation of all therapeutic educational training programs and materials, applying appropriate training and assessment modalities Ensures efficient processes by implementing innovative technologies
  • Janssen-Pharmaceutical Companies Of Johnson & Johnson (Formerly Tibotec)
    Science And Research Liaison
    Janssen-Pharmaceutical Companies Of Johnson & Johnson (Formerly Tibotec) Jun 2007 - Nov 2010
    Be
     Develop peer relationships with Opinion Leaders and discuss the most current trends and developments in the scientific fields of interest to our customers and Tibotec Therapeutics Facilitate novel unsolicited ideas for Investigator Initiated Studies (Phase IV) in the therapeutic area of interest to Tibotec Therapeutics. Integral support for Company Sponsored Trials ( ex. EAP; GRACE, Pregnancy Study, etc) Provide scientific information/education support by responding to unsolicited requests from HCPs for on and off-label Tibotec Therapeutics product specific inquiries. Identify quality educational program opportunities for furthering the knowledge of disease states relevant to Tibotec Therapeutics. Identify and facilitate new business opportunities and communicate to New Business Development and L & A partners Contribute to scientific competitive intelligence efforts Provide Scientific meeting coverage and meeting report for specific internal J&J partners
  • Shands Healthcare/University Of Florida
    Hiv Clinical Specialist
    Shands Healthcare/University Of Florida Aug 2005 - Jun 2007
     Provided patient and family education on adherence, side effects, drug interactions, correct administration of medications Provided drug information to the clinic team; designed new drug regimens via interpretation of genotype/ phenotype resistance patterns Recorded patients’ drug history and updates to ensure proper drug therapy and follow up Education of clinic staff, pharmacy residents, and students on HIV and adjunct drug therapy Ambulatory: Order entry, filling/checking, triage interventions and dispensing of medication in a high volume community setting.
  • University Of Florida School Of Pharmacy
    Clinical Assistant Professor
    University Of Florida School Of Pharmacy Aug 2005 - Jun 2007
    ▪ Assisted with arrangement, preparation and facilitation of multiple courses offered on the Jacksonville campus; Academic Rotation Preceptor▪ College: Pharmacotherapy II & III; Communications, Pharmaceutical Skills Lab▪ Clinical Assistant Professor: Department of Pharmacy, University of Florida▪ Assisted in the organization and case based learning experiences for the third year Jacksonville off-campus pharmacy program; provided review sessions proctored and graded quiz/exams.
  • Bay Pines Va Medical Center
    Infectious Disease Specialty Resident
    Bay Pines Va Medical Center Jul 2004 - Jun 2005
    ASHP Accredited Pharmacy Specialty Residency
  • Durham Va
    Pharmacy Practice Resident
    Durham Va Jul 2003 - Jun 2004
    ASHP Accredited Pharmacy Practice Residency

Kimberley Brown Education Details

  • University Of North Carolina At Chapel Hill
    University Of North Carolina At Chapel Hill
    Pharmacy
  • Fels Institute Of Government At The University Of Pennsylvania
    Fels Institute Of Government At The University Of Pennsylvania
    Board Governance
  • Rutgers Business School
    Rutgers Business School
    Mini-Mba

Frequently Asked Questions about Kimberley Brown

What company does Kimberley Brown work for?

Kimberley Brown works for Viiv Healthcare

What is Kimberley Brown's role at the current company?

Kimberley Brown's current role is Vice President, Global Medical Leader, Cabotegravir.

What is Kimberley Brown's email address?

Kimberley Brown's email address is sb****@****ero.com

What is Kimberley Brown's direct phone number?

Kimberley Brown's direct phone number is +191768*****

What schools did Kimberley Brown attend?

Kimberley Brown attended University Of North Carolina At Chapel Hill, Fels Institute Of Government At The University Of Pennsylvania, Rutgers Business School.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.